Donor cell leukemia: insight into cancer stem cells and the stem cell niche - PubMed (original) (raw)
Review
. 2007 Apr 1;109(7):2688-92.
doi: 10.1182/blood-2006-07-021980.
Affiliations
- PMID: 17132724
- DOI: 10.1182/blood-2006-07-021980
Free article
Review
Donor cell leukemia: insight into cancer stem cells and the stem cell niche
Catherine M Flynn et al. Blood. 2007.
Free article
Abstract
Donor cell leukemia (DCL) is a rare complication of hematopoietic cell transplantation (HCT). Its incidence has been reported between 0.12% and 5%, although the majority of cases are anecdotal. The mechanisms of leukemogenesis in DCL may be distinct from other types of leukemia. Possible causes of DCL include oncogenic alteration or premature aging of transplanted donor cells in an immunosuppressed person. Although many studies have recently better characterized leukemic stem cells, it is important to also consider that both intrinsic cell factors and external signals from the hematopoietic microenvironment govern the developmental fate of hematopoietic stem cells (HSCs). Therefore, in cases of DCL, alteration of the microenvironment after HCT may increase the likelihood that some progeny of normal HSCs become leukemic. This complex intercommunication between cells, growth factors, and cytokines in the hematopoietic microenvironment are critical to balance HSC self-renewal, proliferation, and differentiation. However, this homeostasis is likely perturbed in the development of DCL, allowing unique insight into the stimuli that regulate normal and potentially abnormal hematopoietic development. In this article, we discuss the possible pathogenesis of DCL, its association with stem cells, and its likely dependence on a less-supportive stem cell niche.
Comment in
- Development of original donor cell leukemia after successful engraftment from a second donor.
Stevens JM, Syndercombe-Court D, Oakervee HE, McCloskey D, Jenner MJ, Gribben JG, Cavenagh JD. Stevens JM, et al. Blood. 2007 Dec 15;110(13):4621-2. doi: 10.1182/blood-2007-07-104240. Blood. 2007. PMID: 18056851 Free PMC article.
Similar articles
- Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.
Ruiz-Delgado GJ, León Peña AA, Gómez-de-León A, Ruiz-Argüelles GJ. Ruiz-Delgado GJ, et al. Hematology. 2016 Sep;21(8):470-3. doi: 10.1080/10245332.2015.1117741. Epub 2016 Mar 1. Hematology. 2016. PMID: 26914843 - Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.
Camacho V, McClearn V, Patel S, Welner RS. Camacho V, et al. Int J Hematol. 2017 May;105(5):566-577. doi: 10.1007/s12185-017-2184-6. Epub 2017 Feb 7. Int J Hematol. 2017. PMID: 28176225 Review. - Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
Bouvier A, Ribourtout B, François S, Orvain C, Paz DL, Beucher A, Guérard A, Guardiola P, Ugo V, Blanchet O, Geneviève F, Schmidt A, Hunault-Berger M. Bouvier A, et al. Eur J Haematol. 2018 Oct;101(4):570-574. doi: 10.1111/ejh.13143. Epub 2018 Sep 3. Eur J Haematol. 2018. PMID: 30007088 Review. - Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A, Schwertfeger R, Locasciulli A, Zander A, Bornhäuser M, Niederwieser D, Ruutu T; Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Hertenstein B, et al. Haematologica. 2005 Jul;90(7):969-75. Haematologica. 2005. PMID: 15996934
Cited by
- Donor Cell Myeloid Sarcoma in an Umbilical Cord Transplant Patient: A Case Report and a Review of the Literature.
Hayes C, Petersen B, Malone A. Hayes C, et al. Case Rep Hematol. 2015;2015:186869. doi: 10.1155/2015/186869. Epub 2015 Dec 28. Case Rep Hematol. 2015. PMID: 26823986 Free PMC article. - Influence of the Bone Marrow Microenvironment on Hematopoietic Stem Cell Behavior Post-Allogeneic Transplantation: Development of Clonal Hematopoiesis and Telomere Dynamics.
Kim M, Kang D, Kim HS, Lee JM, Park S, Kwag D, Lee C, Hong Y, Na D, Koh Y, Sun CH, An H, Kim YJ, Kim Y. Kim M, et al. Int J Mol Sci. 2024 Sep 24;25(19):10258. doi: 10.3390/ijms251910258. Int J Mol Sci. 2024. PMID: 39408588 Free PMC article. - Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.
Wong TN, Miller CA, Jotte MRM, Bagegni N, Baty JD, Schmidt AP, Cashen AF, Duncavage EJ, Helton NM, Fiala M, Fulton RS, Heath SE, Janke M, Luber K, Westervelt P, Vij R, DiPersio JF, Welch JS, Graubert TA, Walter MJ, Ley TJ, Link DC. Wong TN, et al. Nat Commun. 2018 Jan 31;9(1):455. doi: 10.1038/s41467-018-02858-0. Nat Commun. 2018. PMID: 29386642 Free PMC article. - Human skin carcinoma arising from kidney transplant-derived tumor cells.
Verneuil L, Varna M, Ratajczak P, Leboeuf C, Plassa LF, Elbouchtaoui M, Schneider P, Sandid W, Lebbé C, Peraldi MN, Sigaux F, de Thé H, Janin A. Verneuil L, et al. J Clin Invest. 2013 Sep;123(9):3797-801. doi: 10.1172/JCI66721. Epub 2013 Aug 27. J Clin Invest. 2013. PMID: 23979160 Free PMC article. - Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system.
Raaijmakers MH. Raaijmakers MH. Haematologica. 2011 Jul;96(7):1041-8. doi: 10.3324/haematol.2010.028035. Epub 2011 Apr 1. Haematologica. 2011. PMID: 21459792 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical